SunXPFanZLiuZLiJHuaQ. Serum osmolarity and contrast-induced nephropathy [published online ahead of print June 5, 2019]. Angiology. doi:10.1177/0003319719853986.
2.
YildizIYildizPORencuzogullariI, et al.Association of serum osmolarity with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2019;70(7):627–32.
3.
GiacoppoDGargiuloGBuccheriS, et al.Preventive strategies for contrast-induced acute kidney injury in patients undergoing percutaneous coronary procedures: evidence from a hierarchical bayesian network meta-analysis of 124 trials and 28 240 patients. Circ Cardiovasc Interv. 2017;10(5):e004383.
4.
ShachamYSteinvilAArbelY. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity. J Nephrol. 2016;29(2):169–74.
5.
SigirciSKeskinKYildizSS, et al.Can thrombus burden predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction?Angiology. 2019;70(7):642–8.
6.
KongTParkYSLeeHS, et al.A delta neutrophil index for the prediction of contrast-induced nephropathy in patients with ST-elevation myocardial infarction followed by percutaneous coronary intervention. Shock. 2018;49(3):317–25.
7.
SunXPLiJZhuWW, et al.Platelet to lymphocyte ratio predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2018;69(1):71–8.
8.
SağSYıldızAAydin KaderliA, et al.Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI. Clin Chem Lab Med. 2017;55(1):132–8.
9.
GoussotSMoussonCGuenanciaC, et al.N-Terminal fragment of pro b-type natriuretic peptide as a marker of contrast-induced nephropathy after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol. 2015;116(6):865–71.
10.
OksuzFYarliogluesMCayS, et al.Predictive value of gamma-glutamyl transferase levels for contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Am J Cardiol. 2015;116(5):711–6.
11.
AkinFCelikOAltunI, et al.Relation of red cell distribution width to contrast-induced acute kidney injury in patients undergoing a primary percutaneous coronary intervention. Coron Artery Dis. 2015;26(4):289–95.
12.
BörekçiAGürMTürkoğluC, et al.Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2015;66(4):339–45.
13.
KayaAKayaYTopçuS, et al.Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65(1):51–6.
14.
Jian-WeiZYu-JieZShu-JunCQingYShi-WeiYBinN. Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65(5):402–7.
